Related Experiment Video

Updated: Mar 21, 2026

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

18.8K

Cardiorenal Syndrome Type 1: Renal Dysfunction in Acute Decompensated Heart Failure

Kurt W Prins1, Thenappan Thenappan1, Jeremy S Markowitz1

  • 1Cardiovascular Division, Department of Internal Medicine, University of Minnesota, Minneapolis, MN.

Journal of Clinical Outcomes Management : JCOM
|May 10, 2016
PubMed

Insights

Cardiorenal syndrome type 1 (CRS1), occurring in one-third of acute decompensated heart failure patients, requires urgent understanding. Further research into CRS1 pathophysiology and treatments is crucial for improving patient outcomes.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Cardiorenal syndrome type 1 (CRS1) is a significant complication of acute decompensated heart failure (ADHF).
  • Approximately one-third of ADHF patients develop CRS1, characterized by acute kidney injury.
  • CRS1 is associated with high-risk outcomes, necessitating a deeper understanding of its mechanisms.

Purpose of the Study:

  • To provide a comprehensive review of cardiorenal syndrome type 1 (CRS1).
  • To discuss the prevalence, pathophysiology, and clinical implications of CRS1.
  • To highlight current treatment strategies and future research directions for CRS1.

Main Methods:

  • Literature review of existing studies on cardiorenal syndrome type 1.
  • Analysis of hemodynamic and nonhemodynamic factors contributing to CRS1 pathophysiology.
  • Evaluation of prognostic variables and treatment data for CRS1.

Main Results:

  • CRS1 affects approximately 33% of patients with ADHF.
  • CRS1 is linked to poor prognosis, emphasizing the need for effective interventions.
  • The review covers prevalence, pathophysiology, prognostic factors, and treatment strategies for CRS1.

Conclusions:

  • Understanding the complex pathophysiology of CRS1 is essential.
  • Development of effective treatments for CRS1 is urgently needed.
  • Further research is critical to address the challenges posed by CRS1.
Abstract

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.4K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.4K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
506
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.7K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.3K